{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:58:51Z","timestamp":1790477931833,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.clinre.2013.06.003","type":"journal-article","created":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T11:30:54Z","timestamp":1375183854000},"page":"e109-e113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Severe chronic hepatitis secondary to prolonged use of ecstasy and cocaine"],"prefix":"10.1016","volume":"37","author":[{"given":"Audrey","family":"Payanc\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Scotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Perarnau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"de Muret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Bacq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2013.06.003_bib0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2174\/138920110791591472","article-title":"MDMA (ecstasy) toxicity: pharmacolinetic, metabolism, cell response and pathological consequences","volume":"11","author":"Fineschi","year":"2010","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.clinre.2013.06.003_bib0010","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0140-6736(92)91469-O","article-title":"Toxicity and deaths from 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d)","volume":"340","author":"Henry","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2013.06.003_bib0015","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/gut.38.3.454","article-title":"Acute liver damage and ecstasy ingestion","volume":"38","author":"Ellis","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2013.06.003_bib0020","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0168-8278(98)80056-1","article-title":"Ecstasy: a common cause of severe acute hepatotoxicity","volume":"29","author":"Andreu","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2013.06.003_bib0025","first-page":"99","article-title":"Ecstasy ingestion and fulminant hepatic failure: liver transplantation to be considered as a last therapeutic option","volume":"43","author":"Garbino","year":"2001","journal-title":"Vet Hum Toxicol"},{"key":"10.1016\/j.clinre.2013.06.003_bib0030","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0168-8278(96)80217-0","article-title":"Chronic ecstasy (3,4-methylenedioxymetamphetamine) abuse: a recurrent and unpredictable cause of severe acute hepatitis","volume":"25","author":"Fidler","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2013.06.003_bib0035","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0168-8278(91)90832-V","article-title":"Hepatic dysfunction accompanying acute cocaine intoxication","volume":"12","author":"Silva","year":"1991","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2013.06.003_bib0040","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/archinte.1991.00400060068011","article-title":"Liver function tests in nonparenteral cocaine users","volume":"151","author":"Kothur","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinre.2013.06.003_bib0045","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0168-8278(91)90826-W","article-title":"Cocaine and the liver","volume":"12","author":"Mallat","year":"1991","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2013.06.003_bib0050","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00004836-199504000-00017","article-title":"Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine (\u201cecstasy\u201d) usage","volume":"20","author":"Khakoo","year":"1995","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.clinre.2013.06.003_bib0055","first-page":"103","article-title":"[Chronic hepatitis with an acute presentation due to ecstasy]","volume":"26","author":"Chaudier","year":"2002","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.clinre.2013.06.003_bib0060","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/10826080500411528","article-title":"Alcohol use and risk taking among regular ecstasy users","volume":"41","author":"Breen","year":"2006","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.clinre.2013.06.003_bib0065","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1148\/rg.296095512","article-title":"MR imaging of liver fibrosis: current state of the art","volume":"29","author":"Faria","year":"2009","journal-title":"Radiographics"},{"key":"10.1016\/j.clinre.2013.06.003_bib0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1365-2036.1999.00454.x","article-title":"Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications","volume":"13","author":"Jones","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2013.06.003_bib0075","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00204-012-0815-5","article-title":"Toxicity of amphetamines: an update","volume":"86","author":"Carvalho","year":"2012","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.clinre.2013.06.003_bib0080","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1006\/bbrc.1999.0803","article-title":"3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d) stimulates the expression of alpha1(I) procollagen mRNA in hepatic stellate cells","volume":"259","author":"Varela-Rey","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clinre.2013.06.003_bib0085","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1124\/dmd.110.032359","article-title":"Differential roles of phase I and phase II enzymes in 3,4-methylendioxymethamphetamine-induced cytotoxicity","volume":"38","author":"Antolino-Lobo","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.clinre.2013.06.003_bib0090","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jhep.2008.01.004","article-title":"Environmental factors as disease accelerators during chronic hepatitis C","volume":"48","author":"Mallat","year":"2008","journal-title":"J Hepatol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740113001332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740113001332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:18:09Z","timestamp":1761895089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740113001332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S2210740113001332"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2013.06.003","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe chronic hepatitis secondary to prolonged use of ecstasy and cocaine","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2013.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}